國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Nanovaccinesan innovative technology...

Gonzalez-Ortega, Omar.

Nanovaccinesan innovative technology to fight human and animal diseases /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Nanovaccinesby Sergio Rosales-Mendoza, Omar Gonzalez-Ortega.
其他題名:	an innovative technology to fight human and animal diseases /
作者:	Rosales-Mendoza, Sergio.
其他作者:	Gonzalez-Ortega, Omar.
出版者:	Cham :Springer International Publishing :2019.
面頁冊數:	x, 343 p. :ill. (some col.), digital ;24 cm.
Contained By:	Springer eBooks
標題:	Vaccines.
電子資源:	https://doi.org/10.1007/978-3-030-31668-6
ISBN:	9783030316686$q(electronic bk.)

Nanovaccinesan innovative technology to fight human and animal diseases /
Rosales-Mendoza, Sergio.

Nanovaccinesan innovative technology to fight human and animal diseases /[electronic resource] :by Sergio Rosales-Mendoza, Omar Gonzalez-Ortega. - Cham :Springer International Publishing :2019. - x, 343 p. :ill. (some col.), digital ;24 cm.

Chapter 1. Nanovaccines and the history of vaccinology -- Chapter 2. The mucosal immune system an outlook for nanovaccines development -- Chapter 3. Gold-based mucosal nanovaccines -- Chapter 4. PLGA-based mucosal nanovaccines -- Chapter 5. Silica-based mucosal nanovaccines -- Chapter 6. Nanogels-based mucosal vaccines -- Chapter 7. Carbon nanotubes-based mucosal vaccines -- Chapter 8. Chitosan-based mucosal nanovaccines -- Chapter 9. Liposomes-based mucosal nanovaccines -- Chapter 10. Virus-like particles-based mucosal nanovaccines -- Chapter 11. Perspectives for field of nanovaccines.

This book provides a compilation of the current developments in mucosal nanovaccines, which are an attractive approach to fight against infectious and non-communicable diseases. Since nanomaterials possess unique properties; many of them have a positive effect on vaccine efficacy when used as antigen carriers and have been applied in vaccinology with significant advances over the past years. This book addresses the methodologies for mucosal nanovaccines synthesis; based on the following nanomaterials: gold, PLGA, silica, and chitosan nanoparticles; as well as nanogels, carbon nanotubes, liposomes, and Virus-like particles. A description of the immunogenic properties of the mucosal nanovaccines is presented, highlighting the improvements achieved with this approach when compared to conventional formulations. Mucosal vaccines constitute the most practical immunization approach since they are easy to administer (promoting patient's comfort and increasing compliance), allow triggering relevant immune responses at both the site of administration and distant compartments, and thus may protect the main entry portal for pathogens (oral, nasal, and genital mucosae) In this context, the potential of nanovaccines to result in new mucosal formulations in the benefit of global health is analyzed. Covers the synthesis and functionalization of nanomaterials for the development of nanovaccines; Discusses the underlying mechanisms involved in the induction of immune responses through mucosal compartments and the advantages of nanomaterials in the formulation of nanovaccines; Transmits the state of the art for the development of mucosal nanovaccines; Provides routes for the design and evaluation of mucosal nanovaccines; Presents key perspectives for the field of mucosal vaccine development.

ISBN: 9783030316686$q(electronic bk.)

Standard No.: 10.1007/978-3-030-31668-6doiSubjects--Topical Terms:

188958
Vaccines.

LC Class. No.: QR189 / .R673 2019

Dewey Class. No.: 615.372

Nanovaccinesan innovative technology to fight human and animal diseases /
LDR:03458nmm a2200337 a 4500 001 569317
003 DE-He213
005 20200206104413.0
006 m d
007 cr nn 008maaau
008 200723s2019 sz s 0 eng d
020 $a 9783030316686$q(electronic bk.)
020 $a 9783030316679$q(paper)
024 7 $a 10.1007/978-3-030-31668-6 $2 doi
035 $a 978-3-030-31668-6
040 $a GP $c GP
041 0 $a eng
050 4 $a QR189 $b .R673 2019
072 7 $a TGM $2 bicssc
072 7 $a TEC021000 $2 bisacsh
072 7 $a TGM $2 thema
072 7 $a TCB $2 thema
082 0 4 $a 615.372 $2 23
090 $a QR189 $b .R788 2019
100 1 $a Rosales-Mendoza, Sergio. $3 747202
245 1 0 $a Nanovaccines $h [electronic resource] : $b an innovative technology to fight human and animal diseases / $c by Sergio Rosales-Mendoza, Omar Gonzalez-Ortega.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a x, 343 p. : $b ill. (some col.), digital ; $c 24 cm.
505 0 $a Chapter 1. Nanovaccines and the history of vaccinology -- Chapter 2. The mucosal immune system an outlook for nanovaccines development -- Chapter 3. Gold-based mucosal nanovaccines -- Chapter 4. PLGA-based mucosal nanovaccines -- Chapter 5. Silica-based mucosal nanovaccines -- Chapter 6. Nanogels-based mucosal vaccines -- Chapter 7. Carbon nanotubes-based mucosal vaccines -- Chapter 8. Chitosan-based mucosal nanovaccines -- Chapter 9. Liposomes-based mucosal nanovaccines -- Chapter 10. Virus-like particles-based mucosal nanovaccines -- Chapter 11. Perspectives for field of nanovaccines.
520 $a This book provides a compilation of the current developments in mucosal nanovaccines, which are an attractive approach to fight against infectious and non-communicable diseases. Since nanomaterials possess unique properties; many of them have a positive effect on vaccine efficacy when used as antigen carriers and have been applied in vaccinology with significant advances over the past years. This book addresses the methodologies for mucosal nanovaccines synthesis; based on the following nanomaterials: gold, PLGA, silica, and chitosan nanoparticles; as well as nanogels, carbon nanotubes, liposomes, and Virus-like particles. A description of the immunogenic properties of the mucosal nanovaccines is presented, highlighting the improvements achieved with this approach when compared to conventional formulations. Mucosal vaccines constitute the most practical immunization approach since they are easy to administer (promoting patient's comfort and increasing compliance), allow triggering relevant immune responses at both the site of administration and distant compartments, and thus may protect the main entry portal for pathogens (oral, nasal, and genital mucosae) In this context, the potential of nanovaccines to result in new mucosal formulations in the benefit of global health is analyzed. Covers the synthesis and functionalization of nanomaterials for the development of nanovaccines; Discusses the underlying mechanisms involved in the induction of immune responses through mucosal compartments and the advantages of nanomaterials in the formulation of nanovaccines; Transmits the state of the art for the development of mucosal nanovaccines; Provides routes for the design and evaluation of mucosal nanovaccines; Presents key perspectives for the field of mucosal vaccine development.
650 0 $a Vaccines. $3 188958
650 0 $a Nanomedicine. $3 273406
650 1 4 $a Biomaterials. $3 274415
650 2 4 $a Medicinal Chemistry. $3 275183
650 2 4 $a Vaccine. $3 337782
650 2 4 $a Nanotechnology. $3 193873
700 1 $a Gonzalez-Ortega, Omar. $3 855278
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
856 4 0 $u https://doi.org/10.1007/978-3-030-31668-6
950 $a Chemistry and Materials Science (Springer-11644)